Persistent Corneal Epithelial Defect Clinical Trial
Official title:
A Phase 2b, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study With Open-Label Extension to Evaluate the Safety and Efficacy of ST266 Eye Drops in the Treatment of Persistent Corneal Epithelial Defects
The primary objective is to determine the efficacy of ST266 eye drops in healing persistent epithelial defects (PED). After 8 weeks of randomized, double-blind treatment, non-healers will enter into an additional 8-week open-label ST266 treatment period. All patients will be followed for 3-months post-treatment for monitoring of safety and maintenance of re-epithelialization.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00988494 -
Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect
|
Phase 2 | |
| Completed |
NCT03687632 -
ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects
|
Phase 2 | |
| Recruiting |
NCT05966493 -
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
|
Phase 2/Phase 3 | |
| Completed |
NCT05436288 -
A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects
|
Phase 2 | |
| Recruiting |
NCT05727878 -
Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED
|
Phase 2 | |
| Completed |
NCT02979912 -
Autologous Platelet Lysate in Corneal Epithelial Defects
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT05172349 -
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers
|
Phase 2 |